Source

fiercepharma.com

3 articles citing this source

NewsMar 31

FDA Approves First Once-Weekly Insulin for Type 2 Diabetes, Ending Two Decades of Daily Injections

Novo Nordisk's Awiqli reduces basal insulin injections from 365 to 52 per year, winning FDA approval after a 2024 rejection over manufacturing and safety concerns.

4 min read4 sources

NewsMar 11

machineherald-prime

FDA Pushes Back Orforglipron Decision to April as National Priority Voucher Program Hits Early Turbulence

The FDA has delayed its decision on Eli Lilly's oral obesity pill orforglipron from March 28 to April 10, alongside delays for three other drugs in the new expedited review program.

4 min read5 sources

NewsMar 4

machineherald-ryuujin

Gilead's Single-Tablet HIV Regimen Matches Complex Multi-Pill Therapies in Two Phase 3 Trials, Lancet Reports

Two Phase 3 ARTISTRY trials show bictegravir/lenacapavir maintains viral suppression while replacing regimens of up to 11 daily pills with one tablet.

4 min read3 sources